Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment.

Zhao Q, Eichten A, Parveen A, Adler C, Huang Y, Wang W, Ding Y, Adler A, Nevins T, Ni M, Wei Y, Thurston G.

Cancer Res. 2018 May 1;78(9):2370-2382. doi: 10.1158/0008-5472.CAN-17-2728. Epub 2018 Feb 15.

PMID:
29449267
2.

Optimal stretching in the reacting wake of a bluff body.

Wang J, Tithof J, Nevins TD, Colón RO, Kelley DH.

Chaos. 2017 Dec;27(12):123109. doi: 10.1063/1.5004649.

PMID:
29289053
3.

Improved Outcomes of Kidney Transplantation in Infants (Age < 2 years): A Single-Center Experience.

Chavers BM, Rheault MN, Matas AJ, Jackson SC, Cook ME, Nevins TE, Najarian JS, Chinnakotla S.

Transplantation. 2018 Feb;102(2):284-290. doi: 10.1097/TP.0000000000001929.

PMID:
28846558
4.

Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.

Wiebe C, Rush DN, Nevins TE, Birk PE, Blydt-Hansen T, Gibson IW, Goldberg A, Ho J, Karpinski M, Pochinco D, Sharma A, Storsley L, Matas AJ, Nickerson PW.

J Am Soc Nephrol. 2017 Nov;28(11):3353-3362. doi: 10.1681/ASN.2017030287. Epub 2017 Jul 20.

PMID:
28729289
5.

Understanding Medication Nonadherence after Kidney Transplant.

Nevins TE, Nickerson PW, Dew MA.

J Am Soc Nephrol. 2017 Aug;28(8):2290-2301. doi: 10.1681/ASN.2017020216. Epub 2017 Jun 19. Review.

PMID:
28630231
6.

Front tracking for quantifying advection-reaction-diffusion.

Nevins TD, Kelley DH.

Chaos. 2017 Apr;27(4):043105. doi: 10.1063/1.4979668.

PMID:
28456164
7.

Outcomes and Risk Factors for Graft Loss: Lessons Learned from 1,056 Pediatric Kidney Transplants at the University of Minnesota.

Chinnakotla S, Verghese P, Chavers B, Rheault MN, Kirchner V, Dunn T, Kashtan C, Nevins T, Mauer M, Pruett T; MNUM Pediatric Transplant Program.

J Am Coll Surg. 2017 Apr;224(4):473-486. doi: 10.1016/j.jamcollsurg.2016.12.027. Epub 2017 Feb 27.

PMID:
28254584
8.

Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.

Rheault MN, Molony JT, Nevins T, Herzog CA, Chavers BM.

Kidney Int. 2017 Jan;91(1):177-182. doi: 10.1016/j.kint.2016.09.013. Epub 2016 Nov 16.

PMID:
27865440
9.

Optimal Stretching in Advection-Reaction-Diffusion Systems.

Nevins TD, Kelley DH.

Phys Rev Lett. 2016 Oct 14;117(16):164502. Epub 2016 Oct 14.

PMID:
27792376
10.

Desirability and feasibility of wireless electronic monitoring of medications in clinical trials.

Robiner WN, Flaherty N, Fossum TA, Nevins TE.

Transl Behav Med. 2015 Sep;5(3):285-93. doi: 10.1007/s13142-015-0316-1.

11.

The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival.

Wiebe C, Nevins TE, Robiner WN, Thomas W, Matas AJ, Nickerson PW.

Am J Transplant. 2015 Aug;15(8):2197-202. doi: 10.1111/ajt.13341. Epub 2015 Jun 11.

12.

Predictive patterns of early medication adherence in renal transplantation.

Nevins TE, Robiner WN, Thomas W.

Transplantation. 2014 Oct 27;98(8):878-84. doi: 10.1097/TP.0000000000000148.

13.

Discovery of siRNA lipid nanoparticles to transfect suspension leukemia cells and provide in vivo delivery capability.

He W, Bennett MJ, Luistro L, Carvajal D, Nevins T, Smith M, Tyagi G, Cai J, Wei X, Lin TA, Heimbrook DC, Packman K, Boylan JF.

Mol Ther. 2014 Feb;22(2):359-370. doi: 10.1038/mt.2013.210. Epub 2013 Sep 3.

14.

RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response.

Yin X, Luistro L, Zhong H, Smith M, Nevins T, Schostack K, Hilton H, Lin TA, Truitt T, Biondi D, Wang X, Packman K, Rosinski J, Berkofsky-Fessler W, Tang JP, Pant S, Geho D, Vega-Harring S, Demario M, Levitsky H, Simcox M.

Clin Cancer Res. 2013 Oct 15;19(20):5686-98. doi: 10.1158/1078-0432.CCR-13-0405. Epub 2013 Aug 23.

15.

Identification of novel, potent and selective inhibitors of Polo-like kinase 1.

Chen S, Bartkovitz D, Cai J, Chen Y, Chen Z, Chu XJ, Le K, Le NT, Luk KC, Mischke S, Naderi-Oboodi G, Boylan JF, Nevins T, Qing W, Chen Y, Wovkulich PM.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1247-50. doi: 10.1016/j.bmcl.2011.11.052. Epub 2011 Dec 1.

PMID:
22172702
16.

Preclinical evaluation of the novel multi-targeted agent R1530.

Kolinsky K, Tovar C, Zhang YE, Railkar A, Yang H, Carvajal D, Nevins T, Geng W, Linn M, Packman K, Liu JJ, Zhang Z, Wovkulich P, Ju G, Higgins B.

Cancer Chemother Pharmacol. 2011 Dec;68(6):1585-94. doi: 10.1007/s00280-011-1608-x. Epub 2011 May 8.

PMID:
21553286
17.

High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097.

He W, Luistro L, Carvajal D, Smith M, Nevins T, Yin X, Cai J, Higgins B, Kolinsky K, Rizzo C, Packman K, Heimbrook D, Boylan JF.

Mol Oncol. 2011 Jun;5(3):292-301. doi: 10.1016/j.molonc.2011.01.001. Epub 2011 Jan 21.

18.

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus disease.

Vezina HE, Brundage RC, Nevins TE, Balfour HH Jr.

Clin Pharmacol. 2010;2:1-7. doi: 10.2147/CPAA.S8341. Epub 2009 Dec 22.

19.

Outcomes of infants <28 days old treated with peritoneal dialysis for end-stage renal disease.

Rheault MN, Rajpal J, Chavers B, Nevins TE.

Pediatr Nephrol. 2009 Oct;24(10):2035-9. doi: 10.1007/s00467-009-1234-6. Epub 2009 Jun 13.

PMID:
19526253
20.

Incidence of cutaneous malignant melanoma in the Ottawa region: 1996 to 2006.

Nevins T, Su Y, Doucette S, Kanigsberg N.

J Cutan Med Surg. 2008 Nov-Dec;12(6):276-81.

PMID:
19317949
21.

Quantitative patterns of azathioprine adherence after renal transplantation.

Nevins TE, Thomas W.

Transplantation. 2009 Mar 15;87(5):711-8. doi: 10.1097/TP.0b013e318195c3d5.

22.

Nonadherence consensus conference summary report.

Fine RN, Becker Y, De Geest S, Eisen H, Ettenger R, Evans R, Rudow DL, McKay D, Neu A, Nevins T, Reyes J, Wray J, Dobbels F.

Am J Transplant. 2009 Jan;9(1):35-41. doi: 10.1111/j.1600-6143.2008.02495.x. Review.

23.

Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients.

Pescovitz MD, Knechtle S, Alexander SR, Colombani P, Nevins T, Nieforth K, Bouw MR.

Pediatr Transplant. 2008 Jun;12(4):447-55. doi: 10.1111/j.1399-3046.2007.00830.x.

PMID:
18466432
24.

Increased urologic complications in children after kidney transplants for obstructive and reflux uropathy.

Khositseth S, Askiti V, Nevins TE, Matas AJ, Ingulli EG, Najarian JS, Gillingham KJ, Chavers BM.

Am J Transplant. 2007 Sep;7(9):2152-7.

25.

In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials.

DePinto W, Chu XJ, Yin X, Smith M, Packman K, Goelzer P, Lovey A, Chen Y, Qian H, Hamid R, Xiang Q, Tovar C, Blain R, Nevins T, Higgins B, Luistro L, Kolinsky K, Felix B, Hussain S, Heimbrook D.

Mol Cancer Ther. 2006 Nov;5(11):2644-58.

26.

Hematuria in children due to schistosomiasis in a nonendemic setting.

Summer AP, Stauffer W, Maroushek SR, Nevins TE.

Clin Pediatr (Phila). 2006 Mar;45(2):177-81.

PMID:
16528439
27.

Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis.

McDermott LA, Higgins B, Simcox M, Luk KC, Nevins T, Kolinsky K, Smith M, Yang H, Li JK, Chen Y, Ke J, Mallalieu N, Egan T, Kolis S, Railkar A, Gerber L, Liu JJ, Konzelmann F, Zhang Z, Flynn T, Morales O, Chen Y.

Bioorg Med Chem Lett. 2006 Apr 1;16(7):1950-3. Epub 2006 Feb 3.

PMID:
16460940
28.

RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: synthesis and biological evaluation.

McDermott LA, Simcox M, Higgins B, Nevins T, Kolinsky K, Smith M, Yang H, Li JK, Chen Y, Ke J, Mallalieu N, Egan T, Kolis S, Railkar A, Gerber L, Luk KC.

Bioorg Med Chem. 2005 Aug 15;13(16):4835-41.

PMID:
15953730
29.

"Why do they do that?" The compliance conundrum.

Nevins TE.

Pediatr Nephrol. 2005 Jul;20(7):845-8. Epub 2005 May 24. Review.

PMID:
15912377
30.

Medication noncompliance: another iceberg's tip.

Nevins TE, Matas AJ.

Transplantation. 2004 Mar 15;77(5):776-8. Review.

PMID:
15021847
32.

Non-compliance and its management in teenagers.

Nevins TE.

Pediatr Transplant. 2002 Dec;6(6):475-9.

PMID:
12453199
33.

The natural history of azathioprine compliance after renal transplantation.

Nevins TE, Kruse L, Skeans MA, Thomas W.

Kidney Int. 2001 Oct;60(4):1565-70.

34.

Management of hemodialysis catheter-related bacteremia--a 10-year experience.

Chawla PG, Nevins TE.

Pediatr Nephrol. 2000 Mar;14(3):198-202.

PMID:
10752756
35.

Overview of new immunosuppressive therapies.

Nevins TE.

Curr Opin Pediatr. 2000 Apr;12(2):146-50. Review.

PMID:
10763765
36.

Kidney transplantation in children younger than 1 year using cyclosporine immunosuppression.

Humar A, Nevins TE, Remucal M, Cook ME, Matas AJ, Najarian JS.

Ann Surg. 1998 Sep;228(3):421-8.

37.
38.

Outcome of chickenpox in 66 pediatric renal transplant recipients.

Kashtan CE, Cook M, Chavers BM, Mauer SM, Nevins TE.

J Pediatr. 1997 Dec;131(6):874-7.

PMID:
9427893
40.
41.

The importance of early cyclosporine levels in pediatric kidney transplantation.

Matas AJ, Gillingham KJ, Chavers BM, Nevins T, Kashtan C, Mauer SM, Payne WD, Gruessner R, Najarian JS.

Clin Transplant. 1996 Dec;10(6 Pt 1):482-6.

PMID:
8996767
42.

Impact of age on renal graft survival in children after the first rejection episode.

Ingulli E, Matas AJ, Nevins TE, Kashtan CE, Mauer SM, Gillingham K, Chavers BM.

Pediatr Nephrol. 1996 Aug;10(4):474-8.

PMID:
8865246
44.

Recipient evaluation, preparation, and care in pediatric transplantation: the University of Minnesota protocols.

Matas AJ, Chavers BM, Nevins TE, Mauer SM, Kashtan CE, Cook M, Najarian JS.

Kidney Int Suppl. 1996 Jan;53:S99-102. Review.

PMID:
8771000
45.

Chronic renal allograft rejection in the first 6 months posttransplant.

Burke BA, Chavers BM, Gillingham KJ, Kashtan CE, Manivel JC, Mauer SM, Nevins TE, Matas AJ.

Transplantation. 1995 Dec 27;60(12):1413-7.

PMID:
8545866
46.

Protein kinase C inhibits human hair follicle growth and hair fibre production in organ culture.

Harmon CS, Nevins TD, Bollag WB.

Br J Dermatol. 1995 Nov;133(5):686-93.

PMID:
8555017
47.

Effects of growth hormone on kidney function in pediatric transplant recipients.

Chavers BM, Doherty L, Nevins TE, Cook M, Sane K.

Pediatr Nephrol. 1995 Apr;9(2):176-81. Review.

PMID:
7794713
48.

Renal transplantation in cyclosporine immunosuppressed infants and children.

Benedetti E, Hakim NS, Matas AJ, Payne WD, Mauer SM, Nevins T, Kashten C, Chavers B, Najarian JS.

Transplant Proc. 1994 Oct;26(5):2766-7. No abstract available.

PMID:
7940871
50.

Hair fibre production by human hair follicles in whole-organ culture.

Harmon CS, Nevins TD.

Br J Dermatol. 1994 Apr;130(4):415-23.

PMID:
8186105

Supplemental Content

Loading ...
Support Center